Overview

Long Term Safety Study of Plecanatide

Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
Multi-center, open-label, long-term safety study
Phase:
Phase 3
Details
Lead Sponsor:
Bausch Health Americas, Inc.
Synergy Pharmaceuticals Inc.
Treatments:
Plecanatide